Back to results
US 6,274,587 B1Granted
Tricyclic dihydropyrimidine potassium channel openers
AssigneeAbbott Laboratories
InventorsMark W. Holladay, William A. Carroll, Irene Drizin, Lin Yi, Henry Q. Zhang
Life of this patent
Estimating the term…
Abstract
Compounds of formula I are useful in treating diseases prevented by or ameliorated with potassium channel openers. Also disclosed are potassium channel opening compositions and a method of opening potassium channels in a mammal.
Claims57
A compound having formula I:
- or a pharmaceutically acceptable salt thereof wherein,
- n is an integer 0-1;
- m is an integer 1-2;
- provided that when m is 2, n is 0;
- R1 is selected from the group consisting of aryl and heterocycle;
- Q is selected from the group consisting of C(O), S(O), and S((O)2;
- V is selected from the group consisting of C(R6)(R7), O, S, and NR2, wherein R2 is selected from the group consisting of hydrogen, alkenyl, alkoxy, alkoxyalkoxy, alkoxyalkyl, alkyl, alkynyl, aryl, arylalkoxy, arylalkenyl, arylalkyl, cyano, cycloalkyl, cycloalkylalkyl, haloalkoxy, haloalkyl, heterocycle, heterocyclealkyl, hydroxy, hydroxyalkyl, —NR4R5, and (NR4R5)alkyl wherein R4 and R5 are independently selected from the group consisting of hydrogen and lower alkyl;
- R6 and R7 are independently selected from the group consisting of hydrogen, alkenyl, alkoxy, alkoxyalkoxy, alkoxyalkyl, alkyl, alkylthio, alkynyl, aryl, arylalkoxy, arylalkenyl, arylalkyl, carboxy, cyano, cycloalkyl, cycloalkylalkyl, haloalkoxy, haloalkyl, halogen, heterocycle, heterocyclealkyl, hydroxy, hydroxyalkyl, oxo, —NR4R5, and (NR4R5)alkyl;
- X is selected from the group consisting of N and CR3, wherein R3 is selected from the group consisting of hydrogen, alkenyl, alkoxy, alkoxyalkoxy, alkoxyalkyl, alkyl, alkylthio, alkynyl, aryl, arylalkoxy, arylalkenyl, arylalkyl, carboxy, cyano, cycloalkyl, cycloalkylalkyl, haloalkoxy, haloalkyl, halogen, heterocycle, heterocyclealkyl, hydroxy, hydroxyalkyl, —NR4R5, and (NR4R5)alkyl;
- A and B are independently selected from the group consisting of hydrogen, alkenyl, alkoxy, alkoxyalkoxy, alkoxyalkyl, alkyl, alkylthio, alkynyl, aryl, arylalkoxy, arylalkenyl, arylalkyl, carboxy, cyano, cycloalkyl, cycloalkylalkyl, haloalkoxy, haloalkyl, halogen, heterocycle, heterocyclealkyl, hydroxy, hydroxyalkyl, —NR4R5, and (NR4R5)alkyl;
- and
- D and E are independently selected from the group consisting of hydrogen, alkenyl, alkoxy, alkoxyalkoxy, alkoxyalkyl, alkyl, alkylthio, alkynyl, aryl, arylalkoxy, arylalkenyl, arylalkyl, carboxy, cyano, cycloalkyl, cycloalkylalkyl, haloalkoxy, haloalkyl, halogen, heterocycle, heterocyclealkyl, hydroxy, hydroxyalkyl, oxo, —NR4R5, and (NR4R5)alkyl.
9 more elements
A method of treating urinary incontinence.
Dependencies are inferred from the claim text.